|
1
|
Kong P, Christia P and Frangogiannis NG:
The pathogenesis of cardiac fibrosis. Cell Mol Life Sci.
71:549–574. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nguyen TP, Qu Z and Weiss JN: Cardiac
fibrosis and arrhythmogenesis: The road to repair is paved with
perils. J Mol Cell Cardiol. 70:83–91. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Coronel R, Wilders R, Verkerk AO,
Wiegerinck RF, Benoist D and Bernus O: Electrophysiological changes
in heart failure and their implications for arrhythmogenesis.
Biochim Biophys Acta. 1832:2432–2441. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Teekakirikul P, Eminaga S, Toka O, Alcalai
R, Wang L, Wakimoto H, Nayor M, Konno T, Gorham JM, Wolf CM, et al:
Cardiac fibrosis in mice with hypertrophic cardiomyopathy is
mediated by non-myocyte proliferation and requires Tgf-β. J Clin
Invest. 120:3520–3529. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Meng XM, Nikolic-Paterson DJ and Lan HY:
TGF-β: The master regulator of fibrosis. Nat Rev Nephrol.
12:325–338. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Khalil H, Kanisicak O, Prasad V, Correll
RN, Fu X, Schips T, Vagnozzi RJ, Liu R, Huynh T, Lee SJ, et al:
Fibroblast-specific TGF-β-Smad2/3 signaling underlies cardiac
fibrosis. J Clin Invest. 127:3770–3783. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Molkentin JD, Bugg D, Ghearing N, Dorn LE,
Kim P, Sargent MA, Gunaje J, Otsu K and Davis J:
Fibroblast-specific genetic manipulation of p38 mitogen-activated
protein kinase in vivo reveals its central regulatory role in
fibrosis. Circulation. 136:549–561. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ma ZG, Yuan YP, Zhang X, Xu SC, Wang SS
and Tang QZ: Piperine attenuates pathological cardiac fibrosis via
PPAR-γ/AKT pathways. EBioMedicine. 18:179–187. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vivar R, Humeres C, Ayala P, Olmedo I,
Catalán M, Garcia L, Lavandero S and Diaz-Araya G: TGF-β1 prevents
simulated ischemia/reperfusion-induced cardiac fibroblast apoptosis
by activation of both canonical and non-canonical signaling
pathways. Biochim Biophys Acta. 1832:754–762. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zaidi SH, Huang Q, Momen A, Riazi A and
Husain M: Growth differentiation factor 5 regulates cardiac repair
after myocardial infarction. J Am Coll Cardiol. 55:135–143. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jiang X, Tsitsiou E, Herrick SE and
Lindsay MA: MicroRNAs and the regulation of fibrosis. FEBS J.
277:2015–2021. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dai Y, Khaidakov M, Wang X, Ding Z, Su W,
Price E, Palade P, Chen M and Mehta JL: MicroRNAs involved in the
regulation of postischemic cardiac fibrosis. Hypertension.
61:751–756. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Matkovich SJ, Wang W, Tu Y, Eschenbacher
WH, Dorn LE, Condorelli G, Diwan A, Nerbonne JM and Dorn GN II:
MicroRNA-133a protects against myocardial fibrosis and modulates
electrical repolarization without affecting hypertrophy in
pressure-overloaded adult hearts. Circ Res. 106:166–175. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pan Z, Sun X, Shan H, Wang N, Wang J, Ren
J, Feng S, Xie L, Lu C, Yuan Y, et al: MicroRNA-101 inhibited
postinfarct cardiac fibrosis and improved left ventricular
compliance via the FBJ osteosarcoma oncogene/transforming growth
factor-β1 pathway. Circulation. 126:840–850. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nagpal V, Rai R, Place AT, Murphy SB,
Verma SK, Ghosh AK and Vaughan DE: MiR-125b is critical for
fibroblast-to-myofibroblast transition and cardiac fibrosis.
Circulation. 133:291–301. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kato M, Putta S, Wang M, Yuan H, Lanting
L, Nair I, Gunn A, Nakagawa Y, Shimano H, Todorov I, et al:
TGF-beta activates Akt kinase through a microRNA-dependent
amplifying circuit targeting PTEN. Nat Cell Biol. 11:881–889. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hou BH, Jian ZX, Cui P, Li SJ, Tian RQ and
Ou JR: miR-216a may inhibit pancreatic tumor growth by targeting
JAK2. FEBS Lett. 589:2224–2232. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xia H, Ooi LL and Hui KM:
MicroRNA-216a/217-induced epithelial-mesenchymal transition targets
PTEN and SMAD7 to promote drug resistance and recurrence of liver
cancer. Hepatology. 58:629–641. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang S, Mi X, Chen Y, Feng C, Hou Z, Hui R
and Zhang W: MicroRNA-216a induces endothelial senescence and
inflammation via Smad3/IκBα pathway. J Cell Mol Med. 22:2739–2749.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang S, Li J, Chen Y, Zhang S, Feng C, Hou
Z, Cai J, Wang Y, Hui R, Lv B and Zhang W: MicroRNA-216a promotes
M1 macrophages polarization and atherosclerosis progression by
activating telomerase via the Smad3/NF-κB pathway. Biochim Biophys
Acta Mol Basis Dis. Jan 26–2018.(Epub ahead of print). doi:
10.1016/j.bbadis.2018.06.016. View Article : Google Scholar :
|
|
23
|
Kato M, Wang L, Putta S, Wang M, Yuan H,
Sun G, Lanting L, Todorov I, Rossi JJ and Natarajan R:
Post-transcriptional up-regulation of Tsc-22 by Ybx1, a target of
miR-216a, mediates TGF-{beta}-induced collagen expression in kidney
cells. J Biol Chem. 285:34004–34015. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
National Research Council (US) Institute
for Laboratory Animal Research, . Guide for the care and use of
laboratory animals. National Academies Press; 1996
|
|
25
|
O'Connell TD, Rodrigo MC and Simpson PC:
Isolation and culture of adult mouse cardiac myocytes. Methods Mol
Biol. 357:271–296. 2007.PubMed/NCBI
|
|
26
|
Geyer FC, Li A, Papanastasiou AD, Smith A,
Selenica P, Burke KA, Edelweiss M, Wen HC, Piscuoglio S, Schultheis
AM, et al: Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT
pathway genes as drivers of breast adenomyoepitheliomas. Nat
Commun. 9:18162018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang X, Ma ZG, Yuan YP, Xu SC, Wei WY,
Song P, Kong CY, Deng W and Tang QZ: Rosmarinic acid attenuates
cardiac fibrosis following long-term pressure overload via
AMPKα/Smad3 signaling. Cell Death Dis. 9:1022018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ma ZG, Yuan YP, Xu SC, Wei WY, Xu CR,
Zhang X, Wu QQ, Liao HH, Ni J and Tang QZ: CTRP3 attenuates cardiac
dysfunction, inflammation, oxidative stress and cell death in
diabetic cardiomyopathy in rats. Diabetologia. 60:1126–1137. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ma ZG, Dai J, Yuan YP, Bian ZY, Xu SC, Jin
YG, Zhang X and Tang QZ: T-bet deficiency attenuates cardiac
remodelling in rats. Basic Res Cardiol. 113:192018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. Aug 12–2015.(Epub ahead of print). doi: 10.7554/eLife.05005.
2015. View Article : Google Scholar
|
|
32
|
Lal H, Ahmad F, Zhou J, Yu JE, Vagnozzi
RJ, Guo Y, Yu D, Tsai EJ, Woodgett J, Gao E and Force T: Cardiac
fibroblast glycogen synthase kinase-3β regulates ventricular
remodeling and dysfunction in ischemic heart. Circulation.
130:419–430. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shojaee S, Chan LN, Buchner M, Cazzaniga
V, Cosgun KN, Geng H, Qiu YH, von Minden MD, Ernst T, Hochhaus A,
et al: PTEN opposes negative selection and enables oncogenic
transformation of pre-B cells. Nat Med. 22:379–387. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lee AA, Dillmann WH, McCulloch AD and
Villarreal FJ: Angiotensin II stimulates the autocrine production
of transforming growth factor-beta 1 in adult rat cardiac
fibroblasts. J Mol Cell Cardiol. 27:2347–2357. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shirakawa K, Endo J, Kataoka M, Katsumata
Y, Yoshida N, Yamamoto T, Isobe S, Moriyama H, Goto S, Kitakata H,
et al: IL (Interleukin)-10-STAT3-galectin-3 axis is essential for
osteopontin-producing reparative macrophage polarization after
myocardial infarction. Circulation. 138:2021–2035. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Horckmans M, Ring L, Duchene J, Santovito
D, Schloss MJ, Drechsler M, Weber C, Soehnlein O and Steffens S:
Neutrophils orchestrate post-myocardial infarction healing by
polarizing macrophages towards a reparative phenotype. Eur Heart J.
38:187–197. 2017.PubMed/NCBI
|
|
37
|
Ma ZG, Zhang X, Yuan YP, Jin YG, Li N,
Kong CY, Song P and Tang QZ: A77 1726 (leflunomide) blocks and
reverses cardiac hypertrophy and fibrosis in mice. Clin Sci (Lond).
132:685–699. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bottinger EP, Jakubczak JL, Roberts IS,
Mumy M, Hemmati P, Bagnall K, Merlino G and Wakefield LM:
Expression of a dominant-negative mutant TGF-beta type II receptor
in transgenic mice reveals essential roles for TGF-beta in
regulation of growth and differentiation in the exocrine pancreas.
EMBO J. 16:2621–2633. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Nie X, Fan J, Li H, Yin Z, Zhao Y, Dai B,
Dong N, Chen C and Wang DW: miR-217 promotes cardiac hypertrophy
and dysfunction by targeting PTEN. Mol Ther Nucleic Acids.
12:254–266. 2018. View Article : Google Scholar : PubMed/NCBI
|
